By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil in 2019, up 77.9% compared to the previous year. Total sales reached...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod employed 774 employees in 2019, down 1.53% compared to the previous year. Historically, betwe...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil with revenues of CZK 25,613 mil in 2019, up by 77.9% and up by 2...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Cash Flow |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod's total assets reached CZK 10,428 mil at the end of 2019, up 1.51% compared to the previous year. Current assets amounted to CZK 7,411 mil, or 71.1% of total assets while cash stood at CZK 96.5 mil at the end ...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod made a net profit of CZK 296 mil in 2019, up 77.9% compared to the previous year. Historically, between 2009 and 2019, the company's net profit reached a high of CZK 296 mil in 2019 and a low of CZK 139 mil in 2015. The resu...
By Helgi Library - June 22, 2021
PHOENIX Lekarensky Velkoobchod's net debt stood at CZK -484 mil and accounted for -18.0% of equity at the end of 2019. The ratio is down 11.3 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of -6.71% in 20...
Phoenix Lekárenský Velkoobchod, a.s. is a Czech Republic-based pharmaceutical distributor. With a market share of nearly 40%, the Company is clearly the leader on the Czech wholesale pharmaceutical market. The Company operates six warehouses throughout the Czech Republic (Praha, Brno, Ostrava, Plzeň, Vysoké Mýto, Ševětín). The Company supplies pharmacies and hospitals with pharmaceutical products, offers warehouse services to pharmaceutical producers and runs a network of its own pharmacies through its subsidiary BENU Česká republika. Phoenix Lekarensky Velkoobchod operates as a subsidiary of PHOENIX Pharmahandel Aktiengesellschaft & Co. KG.
PHOENIX Lekarensky Velkoobchod has been growing its sales by 1.92% a year on average in the last 5 years. EBITDA has fallen on average by 2.47% a year during that time to total of CZK 341 mil in 2019, or 1.33% of sales. That’s compared to 1.37% average margin seen in last five years.
The company netted CZK 296 mil in 2019 implying ROE of 11.6% and ROCE of 6.39%. Again, the average figures were 9.92% and 5.29%, respectively when looking at the previous 5 years.
PHOENIX Lekarensky Velkoobchod’s net debt amounted to CZK -484 mil at the end of 2019, or -18.0% of equity. When compared to EBITDA, net debt was -1.42x, down when compared to average of -0.983x seen in the last 5 years.
Helgi Library 
